9999999997-18-006941.txt : 20180716 9999999997-18-006941.hdr.sgml : 20180716 20180716163738 ACCESSION NUMBER: 9999999997-18-006941 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180716 DATE AS OF CHANGE: 20180716 ACTION DATE: 20180716 RECEIVED DATE: 20180716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Pharma plc CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272179987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 18954785 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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